(PMI) TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that it closed its initial public offering of 4,250,000 shares of common stock, par value $0.0001 per share (the “Common Stock”) at $4.00 per share (the “Offering”). The Company has granted the underwriters an option, within 30 days from the closing date of the Offering, to purchase up to an additional 637,500 shares of Common Stock the public offering price, less underwriting discounts, to cover over-allotment, if any. The gross proceeds from the offering were $17 million, before deducting underwriting discounts and estimated offering expenses. The shares began trading on the NYSE American, LLC (“NYSE American”) under the ticker symbol “PMI” on August 29, 2025.
Related Questions
What are the potential price movements and liquidity implications now that the shares have begun trading on NYSE American under ticker PMI?
How does Picard Medical’s $4.00 IPO pricing and valuation compare to peers in the medical device/healthcare sector, and what does the underwriters’ over‑allotment option suggest about demand?
How will the $17 million IPO proceeds be allocated and what impact will that have on Picard Medical’s growth trajectory?